Try our beta test site
378 studies found for:    Open Studies | "Myelodysplastic Syndromes"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Myelodysplastic Syndromes"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Study of DSP-7888 in Patients With Myelodysplastic Syndrome
Condition: Myelodysplastic Syndrome
Intervention: Drug: DSP-7888
2 Recruiting Phase 1 Study to Evaluate MEDI4736 in Subjects With Myelodysplastic Syndrome
Condition: Myelodysplastic Syndrome
Interventions: Biological: MEDI4736 Evaluate MEDI4736 in MDS;   Drug: VIDAZA;   Biological: tremelimumab
3 Recruiting Study to Evaluate Imetelstat (JNJ-63935937) in Subjects With International Prognostic Scoring System (IPSS) Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS)
Condition: Myelodysplastic Syndromes
Interventions: Drug: Imetelstat;   Drug: Placebo
4 Recruiting 5 Day Versus 7 Day Azacitidine in Lower Risk Myelodysplastic Syndrome
Condition: Myelodysplastic Syndrome
Intervention: Drug: Azacitidine
5 Recruiting PREDICTive FactOR of Overall Survival Among Geriatric Assessment Tools and Disease Related Factors in Elderly Patients With High Risk Myelodysplastic Syndromes.
Condition: Myelodysplastic Syndromes
Interventions: Other: research of disease-related factors;   Other: research of comorbidities;   Other: physical performance
6 Not yet recruiting Pyrimethamine for Intermediate/High-risk Myelodysplastic Syndromes (MDS) That Has Relapsed or Refractory to Azanucleosides
Condition: Myelodysplastic Syndromes
Intervention: Drug: Pyrimethamine
7 Recruiting Observational Evaluation of Infective Risk in Myelodysplastic Syndrome Patients
Condition: Myelodysplastic Syndrome
Intervention: Drug: Antibiotic and antifungal drugs
8 Recruiting Study of REVLIMID (Lenalidomide) Versus Placebo in Patients With Low Risk Myelodysplastic Syndrome
Condition: Myelodysplastic Syndrome
Interventions: Drug: Lenalidomide;   Other: Placebo
9 Recruiting Safety and Efficacy Study of CC-486 and Durvalumab in Subjects With Myelodysplastic Syndromes
Condition: Myelodysplastic Syndromes
Interventions: Drug: CC-486 (ORAL AZACITIDINE);   Drug: Durvalumab
10 Not yet recruiting Safety, Clinical Activity, Pharmacokinetics (PK) and Pharmacodynamics Study of GSK2879552, Alone or With Azacitidine, in Subjects With High Risk Myelodysplastic Syndromes (MDS)
Condition: Myelodysplastic Syndrome
Interventions: Drug: GSK2879552;   Drug: Azacitidine
11 Recruiting The Myelodysplasia Transplantation-Associated Outcomes (MDS-TAO) Study
Condition: Myelodysplastic Syndromes (MDS)
Intervention:
12 Recruiting Sertraline in Treatment of Low-Risk Myelodysplastic Syndrome
Condition: Myelodysplastic Syndromes
Interventions: Drug: Sertraline;   Procedure: Bone Marrow Aspirate/Biopsy
13 Recruiting Evaluation of a Question Prompt List for Patients With Myelodysplastic Syndromes (QPL-MDS)
Condition: Myelodysplastic Syndromes
Interventions: Behavioral: Question prompt list (QPL);   Behavioral: Education brochure of Groupe Français des Myélodysplasies
14 Recruiting ACE-536 Extension Study - Myelodysplastic Syndromes
Condition: Myelodysplastic Syndromes
Intervention: Drug: ACE-536
15 Recruiting Phase I/II Trial to Investigate BI 836858 in Myelodysplastic Syndromes
Condition: Myelodysplastic Syndromes
Interventions: Procedure: Best Supportive Care;   Drug: BI 836858
16 Recruiting Phase 1/2 Study of CG200745 PPA for Myelodysplastic Syndrome
Condition: Myelodysplastic Syndrome
Intervention: Drug: CG200745 PPA
17 Not yet recruiting Dose Escalation and Proof-of-Concept Studies of TEW-7197 Monotherapy in Patients With Myelodysplastic Syndrome (MDS)
Condition: Myelodysplastic Syndromes
Intervention: Drug: TEW-7197
18 Recruiting A Study of Epoetin Beta Treatment in Anemic Participants With Myelodysplastic Syndrome (MDS)
Condition: Myelodysplastic Syndromes
Intervention: Drug: Epoetin beta
19 Recruiting A Phase I/II Study of OPN-305 in Second-line Lower Risk Myelodysplastic Syndrome
Condition: Myelodysplastic Syndrome
Intervention: Drug: OPN-305
20 Recruiting Tipifarnib in Subjects With Transfusion-dependent, Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes
Condition: Myelodysplastic Syndromes
Intervention: Drug: Tipifarnib

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.